{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T21:19:03Z","timestamp":1792876743245,"version":"4.5.0"},"reference-count":28,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["NDT"],"DOI":"10.2147\/ndt.s242084","type":"journal-article","created":{"date-parts":[[2020,6,7]],"date-time":"2020-06-07T22:42:45Z","timestamp":1591569765000},"page":"1411-1426","source":"Crossref","is-referenced-by-count":44,"title":["<p>Safety and Efficacy of Centanafadine Sustained-Release in Adults With Attention-Deficit Hyperactivity Disorder: Results of Phase 2 Studies<\/p>"],"prefix":"10.2147","volume":"Volume 16","author":[{"given":"Sharon B.","family":"Wigal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Wigal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Hobart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica J","family":"Madera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5256-0470","authenticated-orcid":true,"given":"Ross A","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1480-1362","authenticated-orcid":true,"given":"Eva","family":"Kohegyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6401-4661","authenticated-orcid":true,"given":"Anthony","family":"McKinney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy E","family":"Wilens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2020,6]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1177\/1060028013510699","volume":"48","author":"Sharma","year":"2014","journal-title":"Ann Pharmacother"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/j.biopsych.2006.04.022","volume":"60","author":"Berridge","year":"2006","journal-title":"Biol Psychiatry"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1080\/00048670802607238","volume":"43","author":"Levy","year":"2009","journal-title":"Aust N Z J Psychiatry"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/S2215-0366(18)30269-4","volume":"5","author":"Cortese","year":"2018","journal-title":"Lancet Psych"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1177\/0269881113482532","volume":"27","author":"Heal","year":"2013","journal-title":"J Psychopharmacol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuropharm.2014.09.025","volume":"87","author":"Heal","year":"2014","journal-title":"Neuropharmacology"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"107","DOI":"10.2147\/ndt.s1747","volume":"4","author":"Kolar","year":"2008","journal-title":"Neuropsychiatr Dis Treat"},{"key":"ref8","unstructured":"Substance Abuse and Mental Health Services Administration. Results from the 2017 national survey on drug use and health: detailed tables. Available at: https:\/\/www.samhsa.gov\/data\/sites\/default\/files\/cbhsq-reports\/NSDUHDetailedTabs2017\/NSDUHDetailedTabs2017.htm#tab1-25D. Accessed May 15, 2020. Accessed May 17, 2019."},{"key":"ref9","first-page":"111","volume":"10","author":"Bright","year":"2008","journal-title":"Medscape J Med"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1080\/00325481.2015.1083394","volume":"127","author":"Upadhyaya","year":"2015","journal-title":"Postgrad Med"},{"key":"ref11","unstructured":"Atomoxetine [Package Insert]. Indianapolis, IN: Eli Lilly & Co; 2017."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1089\/cap.2014.0005","volume":"24","author":"Bangs","year":"2014","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1001\/jama.2016.5453","volume":"315","author":"Chan","year":"2016","journal-title":"JAMA"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1089\/cap.2008.0080","volume":"19","author":"Sallee","year":"2009","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1002\/syn.21538","volume":"66","author":"Bymaster","year":"2012","journal-title":"Synapse"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/clpt.2010.67","volume":"88","author":"Schoedel","year":"2010","journal-title":"Clin Pharmacol Ther"},{"key":"ref17","volume":"87","author":"Learned","year":"2010","journal-title":"Ann Meeting Am Soc Clin Pharmacol Ther"},{"key":"ref18","first-page":"206","volume":"44","author":"Griffith","year":"1983","journal-title":"J Clin Psychiatry"},{"key":"ref19","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Publishing; 1994."},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Fifth ed. Arlington, VA: American Psychiatric Publishing; 2013.","DOI":"10.1176\/appi.books.9780890425596"},{"key":"ref21","volume-title":"Ritalin: Theory and Practice","year":"2000"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1177\/1087054705286049","volume":"10","author":"Wigal","year":"2006","journal-title":"J Atten Disord"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.3389\/fpsyg.2019.01796","volume":"10","author":"Wigal","year":"2019","journal-title":"Front Psychol"},{"key":"ref24","unstructured":"US Department of Health and Human Services, Food and Drug Administration, Centers for Drug Evaluation and Research (CDER). Assessment of abuse potential of drugs: guidance for industry. January 2017. Available at: https:\/\/www.fda.gov\/downloads\/drugs\/guidances\/ucm198650.pdf. Accessed May 17, 2019."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"754","DOI":"10.4088\/JCP.08m04902pur","volume":"71","author":"Faraone","year":"2010","journal-title":"J Clin Psychiatry"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1007\/s11920-017-0860-0","volume":"30","author":"Wynchank","year":"2017","journal-title":"Curr Psychiatr Rep"},{"key":"ref27","volume-title":"A Phase 2b, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Crossover, Safety and Efficacy Study of Centanafadine Sustained-Release in Adults with Attention-Deficit Hyperactivity Disorder. Presented At: 2019 Annual Meeting of the American Professional Society of ADHD and Related Disorders","year":"2019"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1176\/appi.ajp.160.11.1909","volume":"160","author":"Volkow","year":"2003","journal-title":"Am J Psychiatry"}],"container-title":["Neuropsychiatric Disease and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=58650","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=58650","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,7]],"date-time":"2020-06-07T22:42:50Z","timestamp":1591569770000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/safety-and-efficacy-of-centanafadine-sustained-release-in-adults-with--peer-reviewed-article-NDT"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":28,"URL":"https:\/\/doi.org\/10.2147\/ndt.s242084","relation":{},"ISSN":["1178-2021"],"issn-type":[{"value":"1178-2021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6]]}}}